Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30282
Title: Long-Term Cost-Effectiveness of Severity-Based Triaging for Large Vessel Occlusion Stroke.
Austin Authors: Gao, Lan;Moodie, Marj;Yassi, Nawaf;Davis, Stephen M;Bladin, Christopher F;Smith, Karen;Bernard, Stephen;Stephenson, Michael;Churilov, Leonid ;Campbell, Bruce C V;Zhao, Henry
Affiliation: Medicine (University of Melbourne)
Department of Neurology, Faculty of Medicine, Nursing and Health Sciences, Eastern Health and Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia..
Deakin Health Economics, Institute for Health Transformation, Faculty of Health, Deakin University, Geelong, VIC, Australia..
Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia..
Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia..
Ambulance Victoria, Melbourne, VIC, Australia..
Issue Date: 13-May-2022
Date: 2022
Publication information: Frontiers in neurology 2022; 13: 871999
Abstract: Pre-hospital severity-based triaging using the Ambulance Clinical Triage For Acute Stroke Treatment (ACT-FAST) algorithm has been demonstrated to substantially reduce time to endovascular thrombectomy in Melbourne, Australia. We aimed to model the cost-effectiveness of an ACT-FAST bypass system from the healthcare system perspective. A simulation model was developed to estimate the long-term costs and health benefits associated with diagnostic accuracy of the ACT-FAST algorithm. Three-month post stroke functional outcome was projected to the lifetime horizon to estimate the long-term cost-effectiveness between two strategies (ACT-FAST vs. standard care pathways). For ACT-FAST screened true positives (i.e., screened positive and eligible for EVT), a 52 mins time saving was applied unanimously to the onset to arterial time for EVT, while 10 mins delay in thrombolysis was applied for false-positive (i.e., screened positive but was ineligible for EVT) thrombolysis-eligible infarction. Quality-adjusted life year (QALY) was employed as the outcome measure to calculate the incremental cost-effectiveness ratio (ICER) between the ACT-FAST algorithm and the current standard care pathway. Over the lifetime, ACT-FAST was associated with lower costs (-$45) and greater QALY gains (0.006) compared to the current standard care pathway, resulting in it being the dominant strategy (less costly but more health benefits). Implementing ACT-FAST triaging led to higher proportion of patients received EVT procedure (30 more additional EVT performed per 10,000 patients). The total Net Monetary Benefit from ACT-FAST care estimated at A$0.76 million based on its implementation for a single year. An ACT-FAST severity-triaging strategy is associated with cost-saving and increased benefits when compared to standard care pathways. Implementing ACT-FAST triaging increased the proportion of patients who received EVT procedure due to more patients arriving at EVT-capable hospitals within the 6-h time window (when imaging selection is less rigorous).
URI: https://ahro.austin.org.au/austinjspui/handle/1/30282
DOI: 10.3389/fneur.2022.871999
ORCID: 0000-0002-9807-6606
Journal: Frontiers in neurology
PubMed URL: 35645977
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/35645977/
ISSN: 1664-2295
Type: Journal Article
Subjects: ACT-FAST
direct transfer
large vessel occlusion
stroke
thrombectomy
Appears in Collections:Journal articles

Show full item record

Page view(s)

32
checked on Nov 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.